Buscar
Mostrando ítems 1-10 de 48
Características da degeneração macular relacionada à idade, forma exsudativa, em pacientes brasileiros
(Universidade Federal de Minas GeraisUFMG, 2014-12-19)
Purpose: To report clinical, angiographic and tomographic features of neovascular age-related macular degeneration (AMD) in Brazilian. Methods: Data were collected from patients with newly diagnosed neovascular AMD. Clinical ...
Comparison Between Spectral-Domain and Swept-Source Optical Coherence Tomography Angiographic Imaging of Choroidal Neovascularization
(Assoc Research Vision Ophthalmology Inc, 2017)
PURPOSE. The purpose of this study was to compare imaging of choroidal neovascularization (CNV) using swept-source (SS) and spectral-domain (SD) optical coherence tomography angiography (OCTA). METHODS. Optical coherence ...
Automated Quantitation of Choroidal Neovascularization: A Comparison Study Between Spectral-Domain and Swept-Source OCT Angiograms
(Assoc Research Vision Ophthalmology Inc, 2017)
PURPOSE. To compare the lesion sizes of choroidal neovascularization (CNV) imaged with spectral-domain (SD) and swept-source (SS) optical coherence tomography angiography (OCTA) and measured using an automated detection ...
Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration
(Swets Zeitlinger Publishers, 2001-01-01)
Purpose. To report two cases of occult subfoveal choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) that were successfully treated utilizing large spot, low irradiance 810-nm light and intravenous ...
Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD
(Slack Inc, 2014-11-01)
BACKGROUND and OBJECTIVE: To evaluate the effects of switching to aflibercept in eyes with neovascular age-related macular degeneration (AMD) requiring frequent re-treatment with bevacizumab or ranibizumab.PATIENTS and ...
Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration
(Conselho Brasileiro de Oftalmologia, 2009-10-01)
PURPOSE: To investigate the efficacy of vascular endothelial growth factor-specific (VEGF) monoclonal antibodies in the treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) that ...
Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population
Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients over 55 years. Currently, the most common therapies for neovascular AMD (nAMD) are intravitreal antiangiogenics. Studies suggest ...
New treatment modalities for neovascular age-related macular degeneration
Age-related macular degeneration (AMD) is considered one of the main causes of severe vision loss in older adults. The neovascular form (nAMD) is an advanced stage, which is responsible for the most severe vision loss. ...
Spectral-domain optical coherence tomography imaging of drusenoid pigment epithelial detachments
(Lippincott Williams & Wilkins, 2013-09-01)
Purpose: To evaluate drusenoid retinal pigment epithelial detachments (DPED) secondary to age-related macular degeneration (AMD) using spectral-domain optical coherence tomography imaging.Methods: In this prospective natural ...
Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy
(B M J Publishing Group, 2011-12-01)
The neovascular form of age-related macular degeneration (AMD), called wet-AMD or choroidal neovascularisation, begins with damage to the outer retinal cells and retinal pigment epithelium (RPE), which elicits a cascade ...